Osr Holdings Inc (OSRH)

$0.74 +0.02 (3.25%)
Market Cap 18.40M
Revenue (ttm) 0.00
Net Income (ttm) -2.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.03
Volume 5,470,300
Avg Vol 6,152,050
Day's Range N/A - N/A
Shares Out 25.67M
Stochastic %K 82%
Beta 1.42
Analysts Strong Buy
Price Target N/A

Company Profile

OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is...

Industry: Biotechnology
Sector: Healthcare
Phone: 425 635 7700
Address:
10900 NE 4th Street, Suite 2300, Bellevue, United States
SMARTR8
SMARTR8 Jan. 14 at 2:54 AM
Early or not interested at all 💎 $IRIX from 0.94 👉 now 1.49 (58%+ now) $DVLT from 0.489 👉 1.50 (205%+) $BKKT from 10.55 avg 👉 20 (90%+) $LEXX from 0.506 👉 0.76 (50%+) $OSRH patience will be rewarded. All just recent trades ✅️💎🎯 I have order proof for EVERY trade I ever said I took 🤝
1 · Reply
Spiderman1979
Spiderman1979 Jan. 14 at 2:44 AM
$OSRH so when do we think this license agreement will be sealed.
1 · Reply
M1Tanker
M1Tanker Jan. 14 at 12:54 AM
$OSRH
1 · Reply
M1Tanker
M1Tanker Jan. 14 at 12:53 AM
$OSRH
0 · Reply
HSG28
HSG28 Jan. 14 at 12:47 AM
$OSRH
0 · Reply
elnb
elnb Jan. 14 at 12:41 AM
$OSRH LOL No more shares to left to short From 64% to 131% borrow fee Yeah GL
0 · Reply
Roland115
Roland115 Jan. 14 at 12:22 AM
$OSRH Weak hands out... it's time to go ✅
0 · Reply
FRENESY
FRENESY Jan. 14 at 12:09 AM
$OSRH
0 · Reply
FRENESY
FRENESY Jan. 14 at 12:05 AM
$OSRH 🔥🔥Great news🔥🔥
0 · Reply
transamlover
transamlover Jan. 13 at 11:39 PM
$OSRH
1 · Reply
Latest News on OSRH
Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones

Jan 12, 2026, 8:05 AM EST - 1 day ago

Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones

Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings

Dec 19, 2025, 11:50 AM EST - 25 days ago

Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings

Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target Following Major Licensing Agreement

Dec 4, 2025, 3:19 PM EST - 5 weeks ago

Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target Following Major Licensing Agreement

Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months

Dec 2, 2025, 9:53 AM EST - 6 weeks ago

Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months

OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025

Dec 1, 2025, 3:01 PM EST - 6 weeks ago

OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025

Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones

Nov 21, 2025, 9:20 AM EST - 7 weeks ago

Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones

OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion

Nov 14, 2025, 11:10 AM EST - 2 months ago

OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion

OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study

Nov 6, 2025, 8:30 AM EST - 2 months ago

OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study

Emerging Growth Research Initiates Coverage on OSR Holdings, Inc. with a Buy-Emerging Rating and $10.00 Price Target

Oct 20, 2025, 11:39 AM EDT - 3 months ago

Emerging Growth Research Initiates Coverage on OSR Holdings, Inc. with a Buy-Emerging Rating and $10.00 Price Target

OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care

Oct 14, 2025, 8:30 AM EDT - 3 months ago

OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care

OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity

Sep 9, 2025, 5:30 PM EDT - 4 months ago

OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity

OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025

Aug 1, 2025, 1:29 PM EDT - 5 months ago

OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025

OSR Holdings Provides Transparency Update on Equity Financing Instruments

Jul 31, 2025, 12:45 PM EDT - 5 months ago

OSR Holdings Provides Transparency Update on Equity Financing Instruments

OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure

Jul 30, 2025, 4:10 PM EDT - 5 months ago

OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure

OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology

Jul 24, 2025, 7:30 AM EDT - 6 months ago

OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology

OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company

Jul 15, 2025, 7:30 AM EDT - 6 months ago

OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company

OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG

Jul 9, 2025, 7:58 AM EDT - 6 months ago

OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG

OSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH Token

May 22, 2025, 7:36 AM EDT - 8 months ago

OSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH Token

Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics

May 2, 2025, 7:30 AM EDT - 9 months ago

Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics

Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology

Apr 9, 2025, 7:54 AM EDT - 9 months ago

Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology

OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies

Apr 3, 2025, 7:30 AM EDT - 10 months ago

OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies

Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma

Mar 26, 2025, 7:16 AM EDT - 10 months ago

Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma

OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer

Mar 25, 2025, 7:00 AM EDT - 10 months ago

OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer

OSR Holdings, Inc. and OSR Holdings Co., Ltd. Announce Completion of Business Combination

Feb 14, 2025, 6:10 PM EST - 11 months ago

OSR Holdings, Inc. and OSR Holdings Co., Ltd. Announce Completion of Business Combination

SMARTR8
SMARTR8 Jan. 14 at 2:54 AM
Early or not interested at all 💎 $IRIX from 0.94 👉 now 1.49 (58%+ now) $DVLT from 0.489 👉 1.50 (205%+) $BKKT from 10.55 avg 👉 20 (90%+) $LEXX from 0.506 👉 0.76 (50%+) $OSRH patience will be rewarded. All just recent trades ✅️💎🎯 I have order proof for EVERY trade I ever said I took 🤝
1 · Reply
Spiderman1979
Spiderman1979 Jan. 14 at 2:44 AM
$OSRH so when do we think this license agreement will be sealed.
1 · Reply
M1Tanker
M1Tanker Jan. 14 at 12:54 AM
$OSRH
1 · Reply
M1Tanker
M1Tanker Jan. 14 at 12:53 AM
$OSRH
0 · Reply
HSG28
HSG28 Jan. 14 at 12:47 AM
$OSRH
0 · Reply
elnb
elnb Jan. 14 at 12:41 AM
$OSRH LOL No more shares to left to short From 64% to 131% borrow fee Yeah GL
0 · Reply
Roland115
Roland115 Jan. 14 at 12:22 AM
$OSRH Weak hands out... it's time to go ✅
0 · Reply
FRENESY
FRENESY Jan. 14 at 12:09 AM
$OSRH
0 · Reply
FRENESY
FRENESY Jan. 14 at 12:05 AM
$OSRH 🔥🔥Great news🔥🔥
0 · Reply
transamlover
transamlover Jan. 13 at 11:39 PM
$OSRH
1 · Reply
KeepItRealistic
KeepItRealistic Jan. 13 at 11:32 PM
$OSRH chart looking nice 200 ma at .93 is next resistance
0 · Reply
M1Tanker
M1Tanker Jan. 13 at 11:29 PM
$OSRH 👇👇👇💰💰💰💰
0 · Reply
Lrod0175
Lrod0175 Jan. 13 at 11:10 PM
$OSRH shorts out of shares now👇
0 · Reply
KeepItRealistic
KeepItRealistic Jan. 13 at 10:57 PM
$OSRH l am expecting two more catalysts this week - Woori IO acquisition closure - reaffirmation of price target and possible higher than $10 with this binding term sheet now
0 · Reply
bradleegarlinghouse
bradleegarlinghouse Jan. 13 at 9:12 PM
$OSRH I don’t get it
0 · Reply
M1Tanker
M1Tanker Jan. 13 at 9:06 PM
$OSRH
1 · Reply
M1Tanker
M1Tanker Jan. 13 at 8:57 PM
$OSRH big hitters on X loaded up.
1 · Reply
Scvbbers
Scvbbers Jan. 13 at 8:45 PM
$OSRH Cost to borrow increasing as well
0 · Reply
Scvbbers
Scvbbers Jan. 13 at 8:44 PM
$OSRH Shorts keep adding it seems. Price is going up, squeeze time?
0 · Reply
RM7391
RM7391 Jan. 13 at 8:30 PM
$OSRH wow this is gonna be huge the news hasnt even fully circulated yet imo!!! Amazing news just read the news release again and oh myy $30 million upfront with milestone payments up to 815 million!!!
1 · Reply
bradleegarlinghouse
bradleegarlinghouse Jan. 13 at 8:27 PM
$OSRH They gonna come for this in ah ??? 👀
1 · Reply
Scvbbers
Scvbbers Jan. 13 at 8:16 PM
$OSRH When my shares are at $10 each.
0 · Reply